NBTX · Nanobiotix S.A. · Metrics
$26.50
-0.82 (-2.98%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$1.35B
Shares
50.95M
Volume · Nov 20
125.29K
Avg daily vol (3M)
147.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
NBTX metrics
65 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$26.50
Market cap
$1.35B
Price action
23 metricsPrice change (1W)
-13.6%
Price change (30D)
-9.2%
Price change (3M)
-39.2%
Price change (6M)
-35.4%
Price change (YTD)
+14.6%
Price change (1Y)
+30.0%
Trailing year
Price change (5Y)
+185.9%
52-week high
$55.07
52-week low
$19.97
Change from 52-week high
-51.9%
Change from 52-week low
+32.7%
Annualized volatility
85.1%
Annualized volatility (3M)
82.3%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.8
RSI (14D)
40.2
Price vs SMA 50
-9.6%
Price vs SMA 200
-23.1%
Avg volume (3M)
147,830
Relative volume
0.9
Average dollar volume
$4.75M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
50.95M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
100.6×
reciprocal yield 1.0%
P / book
—
FCF yield
-3.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-04-01
Profitability
9 metricsGross margin
—
Operating margin
-256.8%
Trailing 12 months
Net margin
-459.5%
Gross profit (TTM)
—
Operating profit (TTM)
−$29.55M
Net income (TTM)
−$61.67M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-305.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.42M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
+89.7%
Revenue CAGR (5Y)
+67.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-41.2%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
−$32.74M
Free cash flow (TTM)
−$41.06M
Quick ratio
1.4
Interest coverage
-1.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$126.60M
Total assets
$146.52M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$39.88M
Capital expenditures (TTM)
$1.18M
R&D (TTM)
$24.85M
SG&A (TTM)
−$23.12M
Stock compensation (TTM)
$4.85M
R&D / revenue
185.2%
Stock compensation / revenue
36.1%
Ownership (13F)
9 metrics13F filers
28
13F filer change QoQ
+9
Institutional ownership
12.5%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+10.6%
Holder tenure
11.7
Price vs estimated holder cost
+203.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
36 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1760854
CUSIP
63009J107
13F (30d)
27 filings
25 filers
Visit website
Investor relations